Brisa Aschebrook-Kilfoy, Associate Professor of Family Medicine at UChicago, is an expert in conducting environmental exposure assessments. She is actively leading efforts to build resources to study ...

Oncologists caution that at-home genetic tests taken up by millions of Americans looking to gauge their cancer risk are not ...

Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...

Cases of mouth cancer have reached a record high in England and Scotland, a new report shows. Last year, there were more than ...

Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine ... Dr. Catalina Amador is a ...

Upcoming oral presentation for the ALLOHA ... and translational data in 2025. Solid Tumor Program: TScan continues to expand the ImmunoBank, a collection of therapeutic TCR-Ts that target different ...

Merck KGaA’s $70 million bet on a treatment for a rare, locally aggressive cancer has delivered a phase 3 win. The ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...